Cardiovascular pharmacogenomics: current status, future prospects. - Wikidata - thesis-toulmin - TriplyDB

Cardiovascular pharmacogenomics: current status, future prospects.

Cardiovascular pharmacogenomics: current status, future prospects.

http://www.wikidata.org/entity/Q35090469

about

Pharmacogenomics and drug response in cardiovascular disorders Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm.From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.beta2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation.Ethical problems in pharmacogenetic studies of psychiatric disorders.

P2860

Q28171051-026F31B3-44C9-4183-9DAA-F9D51C5FB636 Q34018308-52F3462F-A7EC-4367-8094-7C6A1CDED3BC Q35812542-FDA0E8AD-C24C-4842-A7C3-6C9649237DD0 Q35814384-4B3AB883-CAE6-41DD-AD47-2D28672D2DAB Q36326202-59B6730B-E6FB-42CD-8664-25FAC8B69BE7 Q48640226-2FB4D8D1-3609-415D-AEB5-8324C67FB0A5 Q51920095-49150232-0747-4A89-AF1A-73ED76318DC1

P2860

Cardiovascular pharmacogenomics: current status, future prospects.

http://www.wikidata.org/entity/Q35090469

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Cardiovascular pharmacogenomics: current status, future prospects.

@ast

Cardiovascular pharmacogenomics: current status, future prospects.

@en

type

label

Cardiovascular pharmacogenomics: current status, future prospects.

@ast

Cardiovascular pharmacogenomics: current status, future prospects.

@en

prefLabel

Cardiovascular pharmacogenomics: current status, future prospects.

@ast

Cardiovascular pharmacogenomics: current status, future prospects.

@en

P1433

Q35090469-B4513C01-EF33-4569-B879-73D44B38B67E

P1476

Q35090469-C43299FF-BC4B-4597-AD5D-0536D18348B8

P2093

Q35090469-9CEC4A02-502F-4F19-AAD0-CD560F5D454C

Q35090469-C38A591F-B91D-47C7-AE83-B6440C9DF0D8

Q35090469-F6BEF7D2-B322-4A10-B5CC-CB6D8EE4392D

Q35090469-FED9DE97-5DEB-46B2-B060-81621E865D29

P2860

Q35090469-03629189-6A07-4B9A-A001-95FDD9A5F24E

Q35090469-04E13586-9955-4E8C-8F5B-37E5ECFC04CA

Q35090469-0CB91EAE-F973-4403-9762-6AFF10062C50

Q35090469-1C292A13-524F-4FDE-8E57-A8C27FC2E7FA

Q35090469-1FEE7550-CC83-40F5-B57E-CF3C6C52101C

Q35090469-255C4000-B15A-4633-82CC-3FC2E2B9716E

Q35090469-2E4920DB-9890-4C39-9C2B-560106E9D553

Q35090469-3A6B3CE2-85ED-4B13-B004-880F345B4807

Q35090469-410733A4-9542-473E-A2BB-6D8358982549

Q35090469-41207DE8-3382-4D4D-95F3-C96DDF16FAF8

P304

Q35090469-2C25BFCE-1D16-4929-B657-B5493121422D

P31

Q35090469-A4918225-F60C-4E1E-A7C5-F1AEDDC17D43

P356

Q35090469-91CACBF6-2E01-4197-A306-293A08209C2A

P433

Q35090469-056CD29B-9BA7-4644-BDF1-5498CF88A878

P478

Q35090469-46A60456-D7D2-4ECD-8FB4-75A0FA9BD13E

P577

Q35090469-1825CE52-F7FE-4032-9FAF-B477EF05AF26

P698

Q35090469-33D02C73-54E5-4EBF-9257-C33CCE60E41E

P921

Q35090469-369974C0-305F-44F6-B1AA-AFD262D6F674

P356

107424840300800I110

P1433

Journal of Cardiovascular Pharmacology and Therapeutics

P1476

Cardiovascular pharmacogenomics: current status, future prospects.

@en

P2093

Benjamin D Horne

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Anderson

http://www.w3.org/2001/XMLSchema#string

John F Carlquist

http://www.w3.org/2001/XMLSchema#string

Joseph B Muhlestein

http://www.w3.org/2001/XMLSchema#string

P2860

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

The Sequence of the Human Genome

A physical map of the human genome

Searching for genetic determinants in the new millennium

The structure of haplotype blocks in the human genome

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

P304

71-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107424840300800I110

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12652332

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics